High level ciprofloxacin resistance in Salmonella enterica isolated from blood

R Raveendran1, C Wattal, A Sharma

  • 1Department of Clinical Microbiology, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi - 110 060, India.

Abstract

Insights

Ciprofloxacin resistance in Salmonella Typhi is a growing concern. Ceftriaxone is now the primary treatment for these resistant infections.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Ciprofloxacin resistance in Salmonella enterica is a significant global health issue.
  • Understanding local susceptibility patterns is crucial for effective treatment.

Purpose of the Study:

  • To determine the antimicrobial susceptibility patterns of Salmonella enterica isolates in a hospital setting.
  • To assess the prevalence of ciprofloxacin resistance in Salmonella Typhi and Paratyphi A.

Main Methods:

  • Blood cultures analyzed using BacT/ALERT 3D system.
  • Antimicrobial susceptibility testing via Kirby-Bauer disc diffusion and CLSI breakpoints.
  • Minimum inhibitory concentration determined for resistant strains using E-test and Vitek-1.

Main Results:

  • 431 Salmonella Typhi and 198 Salmonella Paratyphi A isolates identified.
  • 5.6% of Salmonella Typhi isolates showed ciprofloxacin resistance (22/431).
  • All isolates remained susceptible to ceftriaxone, while resistance to older antibiotics like ampicillin, chloramphenicol, and co-trimoxazole has decreased.

Conclusions:

  • Ciprofloxacin is no longer the preferred treatment for Salmonella infections.
  • Ceftriaxone is the recommended treatment for ciprofloxacin-resistant Salmonella infections.
  • While first-line antimicrobials may retain some utility, ceftriaxone offers reliable efficacy against resistant strains.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...